The preliminary result comes from the first large clinical trial on Covid-19 booster shots conducted when the delta variant was the prevalent strain.
Pfizer Says Its Booster Shot Shows 95.6% Efficacy Against Covid-19
The preliminary result comes from the first large clinical trial on Covid-19 booster shots conducted when the delta variant was the prevalent strain.